查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363963

全球單採市場 2023-2030

Global Apheresis Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 105 Pages | 商品交期: 2-3個工作天內

價格

預計在預測期內（2023-2030 年），全球單採市場將以 8.4% 的年複合成長率成長。市場的成長歸功於全球醫療技術的持續創新。 Spectra Optia 等單採系統提供了創新且有效的治療替代方案，在全球範圍內增加了使用量。在稱為 RBCX 的治療方法中，患者自身的紅血球（通常是患病或有缺陷的細胞）被去除並用健康的供體紅血球替代。除了治療其他自體免疫疾病之外，鐮狀細胞性貧血和其他血紅蛋白疾病等疾病的治療通常還涉及外科手術。因此，市場參與者正在推出新產品來滿足自動化紅血球交換治療的需求。例如，2022年6月，英國NHS英格蘭選擇在該公司的Spectra Optia血漿分離系統上進行自動紅血球交換（RBCX）治療來治療鐮狀細胞疾病。這個選擇導致 Spectra Optia 在英格蘭各地的醫院得到更廣泛的部署。

細分市場前景

全球單採市場按產品、程序和應用進行細分。根據產品，市場分為單採拋棄式用品、單採設備、離心單採設備和薄膜分離設備。根據程序，市場分為自動血液採集、治療性單採、治療性單採拋棄式用品和治療性單採設備。此外，根據應用，市場分為血漿去除術、血小板去除術、紅血球去除術、白血球去除術和光去除術。在這些應用中，由於器官移植排斥治療中對光去除術的需求不斷成長以及血液疾病盛行率的增加，預計光球技術將佔據相當大的市場佔有率。

預計血小板去除術細分市場將在全球單採術市場中佔據相當大的佔有率

在這些應用中，血小板單採細分市場預計將在全球單採市場中佔據相當大的佔有率。該細分市場的成長歸因於全球慢性病盛行率的上升。多種慢性疾病的治療，例如自體免疫疾病、神經系統問題和一些惡性腫瘤，有時涉及血漿分離術。隨著疾病變得更加普遍，對單採手術的需求也越來越大。根據美國國立衛生研究院(NIH) 的數據，2022 年9 月，在接受血小板去除檢查的7,478 名捐贈者中，有3,232 名(43.2%) 出現延誤，其中3,089 名男性(42.5%) 名捐贈者和142 位(63.1%) 位女性捐贈者。 96.5% 的延期是暫時的。其中包括低血紅素(Hb)（7.2%）和低靜脈通路（分別為22.4% 和47.4%）。由於Hb 水平低而導致血紅素下降的捐贈者中，有24.7%（234 名捐贈者中的58 名）的Hb 介於12.0%和12.4%。目前的捐贈者選擇標準開放至最低血紅蛋白12克/分升和最低血小板計數140 103/公升，有可能增加合格的血小板去除捐贈者的數量。

區域展望

全球單採市場根據地理位置進一步細分，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本、韓國、亞太其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，由於人口密度高且老年人口增加，預計亞太地區將在全球市場中佔據顯著佔有率。

北美地區預計全球單採市場將以顯著的年複合成長率成長

在所有地區中，北美地區預計在預測期內將以相當大的年複合成長率成長。除其他單採技術供應商外，自動採血和資訊系統製造商報告稱，對其提供的產品和服務的需求不斷成長。根據美國國立衛生研究院 (NIH) 的數據，2022 年 3 月，由於取消流動捐血活動，固定站點的單採程序總數增加了 37.0%，每張床位的輪次增加了 46.0%；然而，每個捐贈者獲得的產品較少。只要取得所需數量，血小板過期率就從 6.8%（疫情前）降至 4.0% 以下。用於衡量捐血者參與度的捐血頻率從 2020 年 1 月的 1.6 上升到 2021 年 3 月的 1.8。血液中心透過利用諸如自動化血液採集和資訊系統。

市場參與者展望

服務全球單採血液市場的主要公司包括 Cerus Corp.、Crown Bioscience, Inc.、Fresenius SE & Co. KGaA、Haemonetics、Kaneka Corp. 等。市場參與者透過各種策略（包括併購、合作、合作、融資和新產品發布），為市場成長做出了巨大貢獻，以保持市場競爭力。例如，2022 年 8 月，Terumo Blood and Cell Technologies 與 Eliaz Therapeutics Inc. (ETI) 合作，最佳化從血漿中選擇性去除名為 Galectin-3 (Gal-3) 的上游發炎蛋白，以幫助治療 AKI 和S -AKI。

報告涵蓋：

  • 2022年市場價​​值資料分析及2030年預測。
  • 每個細分市場的年化市場收入（百萬美元）。
  • 主要地理區域的國家分析。
  • 全球單採市場的主要公司。根據現有資料，報告中還提供了與新產品發布相關的資訊以及相關新聞。
  • 透過確定未來強勁成長的關鍵細分市場來分析業務策略。
  • 市場進入和市場擴張策略分析。
  • 透過識別市場中「誰的立場」來制定競爭策略。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • Asahi Kasei Corp.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • B. Braun SE
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Baxter International, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 按產品分類的全球單採市場
    • 單採拋棄式用品
    • 單採設備
  • 按程序分類的全球單採市場
    • 自動血液採集（供體血漿分離術）
    • 治療性血漿分離術
  • 按應用分類的全球單採市場
    • 血漿分離術
    • 血小板去除術
    • 紅血球去除手術
    • 白血球去除手術
    • 光採術

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • Cerus Corp.
  • Crown Bioscience, Inc.
  • Fresenius SE & Co. KGaA
  • Haemonetics
  • Kaneka Corp.
  • Macopharma
  • Nikkiso Co., Ltd.
  • Otsuka Holdings Co., Ltd.
  • SB-KAWASUMI LABORATORIES, INC.
  • Terumo BCT
  • Toray Medical Co., Ltd.
Product Code: OMR2027669

Title: Global Apheresis Market Size, Share & Trends Analysis Report by Product (Apheresis Disposables, Apheresis Devices), by Procedure (Automated blood collection, Therapeutic Apheresis), and by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis)Forecast Period (2023-2030).

The global apheresis market is anticipated to grow at a CAGR of 8.4% during the forecast period (2023-2030). The market's growth is attributed to the ongoing innovation in medical technology across the globe. Apheresis systems such as Spectra Optia provide innovative and effective treatment alternatives, increasing usage globally. In a therapeutic treatment known as RBCX, the patient's own red blood cells-often sick or defective cells-are removed and replaced with healthy donor red blood cells. Treatment for diseases like sickle cell anemia and other hemoglobinopathies, in addition to therapy for other autoimmune disorders, frequently involves surgical procedures. Accordingly, market players are coming up with new products to cater the demand for automated red blood cell exchange treatment. For instance, in June 2022, NHS England in the UK has chosen the automated red blood cell exchange (RBCX) treatment carried out on the company's Spectra Optia Apheresis System to treat sickle cell disease. This choice led to a wider deployment of Spectra Optia in hospitals throughout England.

Segmental Outlook

The global apheresis market is segmented on the product, procedure, and application. Based on the product, the market is sub-segmented into apheresis disposables, apheresis devices, centrifugal apheresis devices, and membrane separation devices. Based on the procedure, the market is sub-segmented into automated blood collection, therapeutic apheresis, therapeutic apheresis disposables, and therapeutic apheresis devices. Further, on the basis of application, the market is sub-segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, and photopheresis. Among the application, the photospheres is sub-segment is anticipated to hold a considerable share of the market owing to the growing demand for photopheresis in organ transplant rejection therapies and increased prevalence of blood diseases.

The Plateletpheresis Sub-Segment is Anticipated to Hold a Considerable Share of the Global Apheresis Market

Among the application, the plateletpheresis sub-segment is expected to hold a considerable share of the global apheresis market. The segmental growth is attributed to the rising prevalence of chronic diseases around the globe. Treatment for a variety of chronic diseases, such as autoimmune disorders, neurological issues, and some malignancies, sometimes involves apheresis operations. Apheresis operations are in higher demand as the illnesses become more prevalent. According to the National Institute of Health (NIH), in September 2022, out of the 7,478 donors that were examined for plateletpheresis, 3,232 (43.2%) had delays, with 3,089 (42.5%) men and 142 (63.1%) women donors. 96.5% of extensions have been temporary. Low hemoglobin (Hb) (7.2%) and low venous access (22.4% and 47.4%, respectively, are among them. 24.7% (58 out of 234) of the donors that received a decline owing to the low Hb had a Hb between 12.0% and 12.4 %. The current donor selection criteria opened to a minimum Hb of 12 g/dl and minimum platelet count of 140 103/l, there is potential to increase the number of eligible plateletpheresis donors.

Regional Outlook

The global apheresis market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the high population density with an increase in senior citizen population.

The North America Region is Expected to Grow at a Significant CAGR in the Global Apheresis Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Manufacturers of automated blood collection and information systems in addition to other apheresis technology suppliers report growing demand for the products and services they supply. According to National Institute of Health (NIH), in March 2022, fixed sites increased total apheresis procedures by 37.0% and increased turns per bed by 46.0% as a result of the cancellation of mobile blood drives; however, less products were obtained per donor. Platelet expiration rate went from 6.8% (pre-pandemic) to less than 4.0% by simply obtaining the amount required. Donor frequency, that is used to measure donor involvement, went from 1.6 in January 2020 to 1.8 in March 2021. The blood center increased donor involvement and avoided accumulating an excess of simply specific kind of blood product throughout the epidemic by utilizing technology advancements such as automated blood collection and information systems.

Market Players Outlook

The major companies serving the global apheresis market include Cerus Corp., Crown Bioscience, Inc., Fresenius SE & Co. KGaA, Haemonetics, Kaneka Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in August 2022, Terumo Blood and Cell Technologies, and Eliaz Therapeutics Inc. (ETI), collaborated to optimize the selective removal of an upstream inflammatory protein termed Galectin-3 (Gal-3) from blood plasma to help treat AKI and S-AKI.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global apheresis market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Asahi Kasei Corp.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. B. Braun SE
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Baxter International, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Apheresis Market by Product
    • 4.1.1. Apheresis Disposables
    • 4.1.2. Apheresis Devices
  • 4.2. Global Apheresis Market by Procedure
    • 4.2.1. Automated Blood Collection (Donor Apheresis)
    • 4.2.2. Therapeutic Apheresis
  • 4.3. Global Apheresis Market by Application
    • 4.3.1. Plasmapheresis
    • 4.3.2. Plateletpheresis
    • 4.3.3. Erythrocytapheresis
    • 4.3.4. Leukapheresis
    • 4.3.5. Photopheresis

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Cerus Corp.
  • 6.2. Crown Bioscience, Inc.
  • 6.3. Fresenius SE & Co. KGaA
  • 6.4. Haemonetics
  • 6.5. Kaneka Corp.
  • 6.6. Macopharma
  • 6.7. Nikkiso Co., Ltd.
  • 6.8. Otsuka Holdings Co., Ltd.
  • 6.9. SB-KAWASUMI LABORATORIES, INC.
  • 6.10. Terumo BCT
  • 6.11. Toray Medical Co., Ltd.

LIST OF TABLES

  • 1. GLOBAL APHERESIS MARKET RESEARCH AND ANALYSIS BYPRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL APHERESIS DISPOSABLES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL APHERESIS DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL APHERESIS CENTRIFUGAL DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL MEMBRANE SEPARATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL APHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
  • 7. GLOBAL APHERESIS BASED ON AUTOMATED BLOOD COLLECTION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL APHERESIS BASED ON THERAPEUTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL APHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 10. GLOBAL APHERESIS IN PLASMAPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL APHERESIS IN PLATELETPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL APHERESIS IN ERYTHROCYTAPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL APHERESIS IN LEUKAPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL APHERESIS IN PHOTOPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL APHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN APHERESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN APHERESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN APHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN APHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 20. EUROPEAN APHERESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. EUROPEAN APHERESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 22. EUROPEAN APHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
  • 23. EUROPEAN APHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC APHERESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC APHERESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 26. ASIA-PACIFIC APHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
  • 27. ASIA-PACIFIC APHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD APHERESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD APHERESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD APHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD APHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL APHERESIS MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL APHERESIS DISPOSABLES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL APHERESIS DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL APHERESIS CENTRIFUGAL DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL APHERESIS MEMBRANE SEPARATION DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL APHERESIS MARKET SHARE BY PROCEDURE, 2022 VS 2030 (%)
  • 7. GLOBAL APHERESIS BASED ON AUTOMATED BLOOD COLLECTION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL APHERESIS BASED ON THERAPEUTIC APHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL APHERESIS MARKET SHARE ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 10. GLOBAL APHERESIS IN PLASMAPHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL APHERESIS IN PLATELETPHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL APHERESIS IN ERYTHROCYTAPHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL APHERESIS IN LEUKAPHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL APHERESIS IN PHOTOPHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL APHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. US APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. CANADA APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. UK APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. FRANCE APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. GERMANY APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. ITALY APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. SPAIN APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF EUROPE APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. INDIA APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. CHINA APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. JAPAN APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. SOUTH KOREA APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF ASIA-PACIFIC APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)